loading

Eyepoint Pharmaceuticals Inc Borsa (EYPT) Ultime notizie

pulisher
Jun 17, 2025

Forecasting The Future: 4 Analyst Projections For EyePoint Pharmaceuticals - Benzinga

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Capital Initiates Coverage on EyePoint Pharmaceuticals (EYPT - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

EyePoint Pharmaceuticals (EYPT) Poised for Success with Positive Outlook | EYPT Stock News - GuruFocus

Jun 17, 2025
pulisher
Jun 17, 2025

RBC Capital Initiates EyePoint Pharmaceuticals at Outperform With $28 Price Target - MarketScreener

Jun 17, 2025
pulisher
Jun 16, 2025

After Leaping 47% EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Shares Are Not Flying Under The Radar - simplywall.st

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint (EYPT) Grants Stock Options to New Employees as Inducement | EYPT Stock News - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 563 - GuruFocus

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - EyePoint Pharmaceuticals

Jun 16, 2025
pulisher
Jun 16, 2025

EyePoint Awards 12,500 Shares in Stock Options to Three New Hires at $9.03 Per Share - Stock Titan

Jun 16, 2025
pulisher
Jun 14, 2025

(EYPT) Trading Report - news.stocktradersdaily.com

Jun 14, 2025
pulisher
Jun 12, 2025

EyePoint Stock: Retaining My 'Risky Buy' CallPivotal Data Due Early 2026 (NASDAQ:EYPT) - Seeking Alpha

Jun 12, 2025
pulisher
Jun 11, 2025

Cantor Fitzgerald Weighs in on EYPT FY2026 Earnings - Defense World

Jun 11, 2025
pulisher
Jun 11, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Recommendation of “Buy” from Analysts - Defense World

Jun 11, 2025
pulisher
Jun 10, 2025

EyePoint at Goldman Sachs Healthcare Conference: Sustained-Release Vision By Investing.com - Investing.com Canada

Jun 10, 2025
pulisher
Jun 09, 2025

Breakout Momentum Plays You May Not Know About - Investing.com

Jun 09, 2025
pulisher
Jun 07, 2025

Squarepoint Ops LLC Has $302,000 Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 07, 2025
pulisher
Jun 05, 2025

Ameriprise Financial Inc. Grows Stock Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 05, 2025
pulisher
Jun 04, 2025

Nuveen Asset Management LLC Raises Stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 04, 2025
pulisher
Jun 02, 2025

ProShare Advisors LLC Buys 8,981 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 02, 2025
pulisher
Jun 01, 2025

(EYPT) Investment Report - news.stocktradersdaily.com

Jun 01, 2025
pulisher
Jun 01, 2025

MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Has $276,000 Stock Holdings in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

Jun 01, 2025
pulisher
May 31, 2025

Eyepoint projects DURAVYU Phase 3 enrollment completion by H2 2025 amid strong clinical trial momentum - MSN

May 31, 2025
pulisher
May 31, 2025

Millennium Management LLC Buys New Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 31, 2025
pulisher
May 30, 2025

EyePoint advances with Duravyu Phase III trial - Yahoo

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Buy on EyePoint with $22 target - Investing.com India

May 30, 2025
pulisher
May 30, 2025

H.C. Wainwright maintains Buy on EyePoint with $22 target By Investing.com - Investing.com Nigeria

May 30, 2025
pulisher
May 30, 2025

EyePoint Pharmaceuticals (NASDAQ:EYPT) shareholders are up 29% this past week, but still in the red over the last year - simplywall.st

May 30, 2025
pulisher
May 30, 2025

EyePoint Pharmaceuticals’ (EYPT) Buy Rating Reaffirmed at HC Wainwright - Defense World

May 30, 2025
pulisher
May 29, 2025

Biggest Companies on Nasdaq EyePoint Pharmaceuticals Insights by Kalkine - Kalkine Media

May 29, 2025
pulisher
May 29, 2025

Analyst Expectations For EyePoint Pharmaceuticals's Future - Benzinga

May 29, 2025
pulisher
May 29, 2025

EyePoint Pharmaceuticals (EYPT) Reiterates Buy Rating with $22 P - GuruFocus

May 29, 2025
pulisher
May 29, 2025

EyePoint Pharmaceuticals (EYPT) Reiterates Buy Rating with $22 Price Target | EYPT Stock News - GuruFocus

May 29, 2025
pulisher
May 29, 2025

Bank of America Corp DE Acquires 145,065 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 29, 2025
pulisher
May 28, 2025

EyePoint Announces Participation at Upcoming Investor Conferences - The Manila Times

May 28, 2025
pulisher
May 28, 2025

EyePoint Secures Triple Conference Spotlight: Goldman Sachs, Jefferies, and Guggenheim Healthcare Events - Stock Titan

May 28, 2025
pulisher
May 28, 2025

EYPTEyepoint Pharmac Latest Stock News & Market Updates - Stock Titan

May 28, 2025
pulisher
May 27, 2025

EyePoint at Stifel Forum: Strategic Advances in Ophthalmology By Investing.com - Investing.com Canada

May 27, 2025
pulisher
May 27, 2025

JPMorgan maintains EyePoint stock Overweight with $26 target - Investing.com India

May 27, 2025
pulisher
May 27, 2025

JPMorgan maintains EyePoint stock Overweight with $26 target By Investing.com - Investing.com UK

May 27, 2025
pulisher
May 27, 2025

Eyepoint Completes Enrollment In Pivotal Phase 3 Lugano Trial Of Duravy For Treatment Of Wet Age-Related Macular Degeneration - marketscreener.com

May 27, 2025
pulisher
May 27, 2025

EyePoint (EYPT) Surpasses Enrollment Goal in Key Phase 3 Trial | - GuruFocus

May 27, 2025
pulisher
May 27, 2025

EyePoint Completes Enrollment for DURAVYU Phase 3 Trial - TipRanks

May 27, 2025
pulisher
May 27, 2025

EyePoint Pharmaceuticals Reports Rapid Enrollment Progress in Phase 3 LUGANO Trial of DURAVYU™ for Wet AMD Treatment - Nasdaq

May 27, 2025
pulisher
May 27, 2025

EyePoint Completes Enrollment in Pivotal Phase 3 LUGANO Trial of DURAVYU™ for Treatment of Wet Age-Related Macular Degeneration - The Manila Times

May 27, 2025
pulisher
May 27, 2025

Clinical Trial Milestone: EyePoint's Revolutionary 6-Month Eye Treatment Completes Phase 3 Enrollment - Stock Titan

May 27, 2025
pulisher
May 26, 2025

EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors - The Globe and Mail

May 26, 2025
pulisher
May 25, 2025

Deutsche Bank AG Has $1.59 Million Stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 25, 2025
pulisher
May 24, 2025

BNP Paribas Financial Markets Purchases New Shares in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 24, 2025
pulisher
May 22, 2025

(EYPT) Trading Signals - news.stocktradersdaily.com

May 22, 2025
pulisher
May 22, 2025

Northern Trust Corp Has $4.79 Million Stake in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 22, 2025
pulisher
May 19, 2025

Insider Buying: Karen Zaderej Acquires Additional Shares of EyeP - GuruFocus

May 19, 2025
pulisher
May 19, 2025

Insider Buying: Karen Zaderej Acquires Additional Shares of EyePoint Pharmaceuticals Inc (EYPT) - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Dimensional Fund Advisors LP Sells 2,063 Shares of EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 18, 2025
pulisher
May 17, 2025

The Manufacturers Life Insurance Company Boosts Position in EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) - Defense World

May 17, 2025
pulisher
May 17, 2025

EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT) Receives Average Rating of “Buy” from Brokerages - Defense World

May 17, 2025
pulisher
May 16, 2025

EyePoint Pharmaceuticals (EYPT) Target Price Lowered by Mizuho Analyst | EYPT Stock News - GuruFocus

May 16, 2025
pulisher
May 16, 2025

EyePoint (EYPT) Faces Price Target Reduction by Mizuho | EYPT St - GuruFocus

May 16, 2025
$21.16
price down icon 1.86%
$34.86
price down icon 0.14%
$20.56
price up icon 1.98%
$102.68
price up icon 3.24%
$106.53
price up icon 2.04%
biotechnology ONC
$247.08
price down icon 2.25%
Capitalizzazione:     |  Volume (24 ore):